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Abstract 
Quercetin is one of the most commonly occurring flavonoids in nature. Although, quercetin 
and its metabolites express negligible fluorescence, the albumin-bound form of quercetin has 
a strong fluorescence property. Considering the structural variance of different albumins, we 
hypothesized that the fluorescence of albumin complexes of quercetin and its metabolites may 
vary significantly. Therefore, in this study the fluorescence enhancement of quercetin and 
some of its major metabolites in the presence of bovine (BSA), human (HSA), porcine (PSA), 
and rat serum albumins (RSA) were investigated by steady-state fluorescence spectroscopy in 
PBS buffer (pH 7.4). Among the tested quercetin metabolites, significant fluorescence signal 
was shown by albumin complexes of quercetin, isorhamnetin, and quercetin-3’-sulfate, while 
other metabolites (tamarixetin, quercetin-3-glucuronide, and isorhamnetin-3-glucuronide) 
expressed negligible fluorescence. BSA was the most potent enhancer of quercetin-3’-sulfate 
but it showed poor effects regarding other flavonoids. The strongest enhancement of 
isorhamnetin was caused by HSA, while it was less effective enhancer of quercetin and 
quercetin-3’-sulfate. PSA showed a strong fluorescence enhancement of quercetin and 
quercetin-3’-sulfate but it was poorly effective regarding isorhamnetin. RSA was the most 
potent enhancer of quercetin but it caused only a weak enhancement of isorhamnetin and 
quercetin-3’-sulfate. Large changes of the pH (such as pH 5.0 and pH 10.0) almost completely 
abolished the fluorescence signals of the complexes. Nevertheless, slight decrease (pH 7.0) 
reduced and slight increase (pH 7.8) generally enhanced the fluorescence of flavonoid-
albumin complexes (only exceptions were quercetin-PSA and quercetin-RSA). Complex 
formations were also investigated by fluorescence quenching studies. Based on our results, 
the formations of quercetin-BSA, quercetin-HSA, isorhamnetin-BSA, isorhamnetin-HSA, 
isorhamnetin-PSA, and quercetin-3’-sulfate – HSA complexes followed 1:1 stoichiometry, 
while the presence of a secondary binding site of flavonoids was assumed regarding other 
 3 
 
tested albumin complexes. Our study highlights that albumins can induce significantly 
different fluorescence enhancement of flavonoids, and even the stoichiometry of flavonoid-
albumin complexes may differ. 
 
Keywords: quercetin, isorhamnetin, quercetin-3’-sulfate, albumin, fluorescence spectroscopy
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1. Introduction 
Flavonoids are ubiquitous polyphenolic compounds in the plant kingdom. They appear in 
several fruits and vegetables, in numerous dietary supplements, herbal medicines, and in some 
medications [1,2]. One of the most frequently occurring flavonoids is quercetin which is an 
extensively studied molecule because of its complex mechanism of action and manifold 
pharmacological effects in the human organism [3-5]. Beyond that quercetin is part of the diet, 
many commercially available dietary supplements contain extremely high doses of quercetin 
[6]. After its oral consumption or administration, quercetin undergoes significant presystemic 
elimination [7-10]. During its biotransformation, sulfate and glucuronide conjugates as well as 
methylated metabolites of quercetin are formed [11,12]. In the human circulation, the parent 
compound quercetin represents only a few percent of the total quercetin, while quercetin-3’-
sulfate (Q3’S) is the dominant circulating metabolite [12]. Furthermore, 3’- and 4’-
methylation of quercetin by catechol-O-methyltransferase (COMT) enzyme result in the 
formation of isorhamnetin (IR; 3’-O-methylquercetin) and tamarixetin (4’-O-methylquercetin), 
respectively [8,13].  
Albumin is the most abundant plasma protein in humans and animals. Albumin maintains the 
oncotic pressure of the blood, and it is able to form stable complexes with several compounds 
(including fatty acids, hormones, amino acids, bile acids, metals, drugs, natural compounds, 
and xenobiotics) which can strongly affect the distribution and elimination of these ligand 
molecules [14,15]. Therefore, albumin can significantly influence the pharmacokinetic 
properties of these substances [16-18]. Previous studies demonstrated that quercetin forms 
stable complexes with human serum albumin (HSA) and bovine serum albumin (BSA), 
occupying Sudlow’s Site I (on subdomain IIA, which is the primary binding site of warfarin 
as well) [19-25]. However, a recent study suggest that flavonoid aglycones do not bind at 
warfarin high affinity site, but rather to different regions within the IIA subdomain of HSA 
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[26]. Investigation of quercetin-albumin interaction is an important issue because the complex 
formation may have both therapeutic advantages and unpleasant consequences. Based on 
previous studies, albumin nanoparticles can promote the stability of quercetin in the intestinal 
fluid [27], and albumin improves the positive effect of quercetin on survival of erythrocytes in 
visceral leishmaniasis [28]. On the other hand, the competitive interaction of quercetin with 
other Sudlow’s Site I ligands can result in the displacement of drugs from albumin which may 
responsible for the disruption of drug therapy [24,29-32]. In addition, other investigations also 
highlighted the strong interaction of quercetin metabolites with HSA [6,33,34] which is very 
important because of the extensive biotransformation of quercetin in the body [4,7,12]. 
Albumin-ligand interactions are commonly investigated by fluorescence spectroscopy due to 
the quenching of the tryptophan residue(s) of albumins can be precisely followed with this 
technique. Besides quenching studies, some of the fluorescence investigations of quercetin-
albumin interactions highlighted that the non-fluorescent (or poorly fluorescent) quercetin 
shows strong fluorescence in its albumin-bound form [20-22]. Despite their similarities, 
different albumin species show large variance regarding their interaction with ligand 
molecules [35,36]. Therefore, it is plausible to hypothesize that different albumins may cause 
significantly different fluorescence enhancement of quercetin or its metabolites. 
In this study, the influence of BSA, HSA, porcine serum albumin (PSA), and rat serum 
albumin (RSA) on the fluorescence properties of quercetin and its metabolites (including IR, 
Q3’S, tamarixetin, quercetin-3-glucuronide, and isorhamnetin-3-glucuronide) was 
investigated. Since among the tested compounds, only quercetin, IR, and Q3’S (Fig. 1) gave 
significant fluorescence signals in the presence of albumins, complex formation of these 
flavonoids with the four different albumins were further investigated. During the high 
quercetin intake (through the consumption of dietary supplements and herbal medications), 
high concentrations of quercetin and its metabolites can reach the circulation. Therefore, the 
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deeper understanding of the flavonoid-albumin complex formations may give us important 
and pharmacologically relevant information. Furthermore, extrapolation of animal 
experiments to humans is commonly a controversial issue; therefore, similarities or 
differences between the binding abilities of flavonoid molecules to human and animal 
albumins are also important. In addition, the fluorescence enhancement of quercetin, IR, and 
Q3’S by albumins makes possible the fluorescence spectroscopic detection and investigation 
of these poorly fluorescent molecules. 
 
2. Materials and methods 
2.1. Reagents 
All applied chemicals were of spectroscopic or analytical grade. Quercetin dihydrate (Q; 
product code: 1135S, purity: ≥99% based on HPLC), isorhamnetin (IR; product code: 1120S, 
purity: ≥99%, HPLC), and tamarixetin (product code: 1140S, purity: ≥99%, HPLC) were 
from Extrasynthese. Human serum albumin (HSA; product code: A1653, purity: ≥96%, 
agarose gel electrophoresis), bovine serum albumin (BSA; product code: A2153, purity: 
≥98%, agarose gel electrophoresis), porcine serum albumin (PSA; product code: A1830, 
purity: ≥98%, agarose gel electrophoresis), and rat serum albumin (RSA; product code: 
A6272, purity: ≥96%, agarose gel electrophoresis) were purchased from Sigma-Aldrich. 
Quercetin-3’-sulfate (Q3’S), quercetin-3-glucuronide, and isorhamnetin-3-glucuronide (purity 
of each conjugate: >95%, HPLC) were synthetized as described elsewhere [37]. 2000 μM 
stock solutions of flavonoids were prepared in spectroscopic grade dimethyl sulfoxide (Fluka); 
thereafter these solutions were diluted (in more steps) by the appropriate buffers (for example 
PBS) in order to produce the samples. Most of the measurements were carried out in PBS 
buffer (phosphate buffered saline, pH 7.4) in order to mimic extracellular physiological 
environment, because this buffer contains very similar concentrations of sodium, potassium, 
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and chloride ions which are typical of the extracellular space (including blood). To examine 
the influence of pH on the fluorescence enhancement of flavonoids by albumins, 0.05 M 
sodium acetate (pH 5.0), 0.05 M sodium-borate (pH 10.0), and PBS (pH 7.0 and 7.8) buffers 
were applied as well.   
 
2.2. Spectroscopic measurements 
Fluorescence spectra were recorded employing a Hitachi F-4500 fluorescence 
spectrophotometer (Tokyo, Japan). To test the influence of different albumins on the 
fluorescence signal of flavonoids, increasing albumin concentrations (0, 0.5, 1.0, 1.5, 2.0, 3.0, 
4.0, and 5.0 μM) were added to 2 μM flavonoid. Then fluorescence emission spectra were 
recorded using 445 nm (Q3’S) or 455 nm (quercetin and IR) as excitation wavelengths.  
In order to investigate the complex formations of flavonoids with albumins, fluorescence 
quenching method was applied. During these experiments, increasing flavonoid 
concentrations (0, 0.5, 1.0, 2.0, 3.0, 4.0, 5.0, and 6.0 μM) were added to 2 μM albumin. 
Fluorescence emission spectra of albumins were recorded using 295 nm as excitation 
wavelength. Quenching experiments were evaluated based on the graphical application of the 
Stern-Volmer equation: 
][10 QK
I
I
SV   (1) 
where I0 and I are fluorescence emission intensities of albumin with and without flavonoids, 
respectively. KSV is the Stern-Volmer quenching constant while [Q] is the concentration of the 
flavonoid. Thereafter, based on the quenching data, binding constants (K) were quantified 
using the graphical application of double logarithm Stern-Volmer equation as well [38,39]: 
]lg[lg
)(
lg 0 QnK
I
II


 (2) 
where n is the number of binding sites on albumin.  
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Overall and stepwise binding constants were calculated by non-linear fitting the fluorescence 
emission data obtained for all the performed experiments (quenching of the albumin’s 
fluorescence by flavonoids, and fluorescence enhancement of flavonoids by albumins) with 
the Hyperquad2006 program package [40,41]. To calculate the stability constants associated 
with the complex formation between albumins (A) and flavonoids (F), the following equations 
are implemented in the Hyperquad code: 
qpFAqFpA   (3) 
qp
qp
pq
FA
FA
K
][][
][
  (4) 
where p and q are the coefficients that indicate the stoichiometry associated with the possible 
equilibria in the solution. In Hyperquad2006 computer fitting program all equilibrium 
constants are defined as overall association/binding constants.  
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The relationship between the overall association/binding constants and the stepwise 
association/binding constants calculated by the Hyperquad is the following. 
qq KKKKKK  ...;; 2121211   (8) 
The stoichiometry and association/binding constants of the complexes were determined by the 
model associated with the lowest standard deviation.  
 
3. Results and discussion 
 9 
 
3.1. Fluorescence spectra of quercetin and quercetin metabolites in the presence of different 
albumins 
First, the fluorescence excitation and emission spectra of 2 μM concentrations of quercetin 
and its metabolites – including isorhamnetin, quercertin-3’-sulfate, quercetin-3-glucuronide, 
isorhamnetin-3-glucuronide, and tamarixetin – were recorded in PBS buffer. Under the 
applied circumstances, the tested flavonoids showed no considerable fluorescence signals. 
Thereafter, increasing concentrations of BSA, HSA, PSA, and RSA (0-5 μM) were added to 
the standard 2 μM flavonoid concentrations. The presence of elevating albumin levels resulted 
in the significant fluorescence enhancement of quercetin, IR, and Q3’S (Fig. 2, Fig. 3, and Fig. 
S1). Albumins themselves did not show fluorescence signal under the applied conditions. We 
observed negligible fluorescence of quercetin-3-glucuronide, isorhamnetin-3-glucuronide, and 
tamarixetin, even in the presence of 5 μM albumin concentrations, regardless the albumin 
applied (data not shown). In our previous study, we demonstrated that tamarixetin binds with 
slightly lower (logK = 5.19) while quercetin-3-glucuronide and isorhamnetin-3-glucuronide 
bind with much lower (logK values were 4.73 and 4.55, respectively) affinities to HSA 
compared to the parent compound quercetin (logK = 5.37) [6]. Despite their significant 
interaction with albumin, glucuronide metabolites and tamarixetin did not show strong 
fluorescence signal in their albumin-bound form.  
In the presence of albumins, quercetin and IR showed fluorescence excitation maximum at 
455 nm, while Q3’S expressed its maximal excitation intensity at 445 nm (quercetin and IR: 
λem = 525 nm; Q3’S: λem = 505 nm). Using these excitation wavelengths, emission spectra of 
flavonoid-albumin complexes were recorded (Fig. 3). Interestingly, the presence of different 
albumins led to quite different fluorescence emission intensities (Fig. 2). Regarding quercetin, 
complexation with BSA caused the weakest while complex formation with RSA resulted in 
the strongest fluorescence, and significant differences were observed in the presence of each 
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tested albumin (Fig. 2, left). Similar fluorescence signals of IR-albumin complexes were 
observed in the presence of BSA, PSA, and RSA; however, HSA showed much stronger 
effect compared to the other tested albumins (Fig. 2, middle). Furthermore, very strong 
increase of the fluorescence signal of Q3’S was observed in the presence of BSA, while HSA, 
PSA, and RSA had weaker effects showing distinct fluorescence intensities (Fig. 2, right). 
Q3’S-BSA complex showed the highest fluorescence among each tested flavonoid-albumin 
combination, strongly exceeding the fluorescence signals of both quercetin-RSA and IR-HSA 
complexes. Our results are consistent with previous studies which describes that quercetin in 
HSA-bound form expresses significant fluorescence at 525 nm [20-22]; however, the 
fluorescence of other quercetin-albumin complexes as well as the fluorescence enhancement 
of IR and Q3’S by albumins were not reported previously. Therefore, our results offer a good 
starting point to quantify quercetin, IR, and Q3’S (in fact, their albumin complexes) with 
fluorescence methods. 
 
3.2. Effect of the pH on the fluorescence enhancement of quercetin, IR, and Q3’S by albumins   
Our results highlighted that albumins are able to significantly improve the fluorescence 
properties of quercetin, IR, and Q3’S under extracellular physiological conditions. However, 
we were curious how the changes of the environmental pH can influence the fluorescence 
signals of these flavonoid-albumin complexes; therefore, only in this part of our experiments, 
measurements were carried out in non-physiological buffers as well. Fluorescence spectra of 
quercetin, IR, and Q3’S were recorded in sodium acetate (pH 5.0) and in sodium borate (pH 
10.0) buffers. Under these circumstances, the fluorescence intensities of the flavonoid-
albumin complexes were significantly decreased compared to their signals in PBS at pH 7.4 
(such as Q3’S-BSA and Q3’S-HSA) or almost completely abolished (in each other case). 
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Thereafter, the influence of slight pH changes were tested in the same buffer as well. 
Fluorescence spectra of flavonoid-albumin complexes were recorded in PBS at pH 7.0, 7.4, 
and 7.8. Fig. 4 demonstrates that in most of the cases, slight decrease of the pH reduces while 
slight increase of the pH enhances the fluorescence of the tested flavonoid-albumin 
complexes. On the other hand, quercetin-PSA and quercetin-RSA complexes did not follow 
this principle because both the slight decrease and increase of the pH resulted in reduced 
fluorescence signals. Furthermore, our results also highlighted that the extent or magnitude of 
the fluorescence changes show strong differences. Altogether, we can state that the 
environmental pH significantly influences the fluorescence signal of the examined flavonoid-
albumin complexes. 
 
3.3. Fluorescence quenching studies 
In order to get more information regarding the flavonoid-albumin complex formations, 
fluorescence quenching studies were performed. During this part of the study, increasing 
quercetin, IR, and Q3’S concentrations (0-6 μM) were added to 2 μM albumin. Fluorescence 
emission spectra of albumins in the absence and presence of flavonoids were recorded in PBS 
(pH 7.4) using 295 nm as excitation wavelength. As Fig. 5 demonstrates, increasing flavonoid 
concentrations resulted in the significant decrease of the fluorescence emission intensities at 
334 nm. Flavonoids alone did not show fluorescence under the applied circumstances. Before 
the evaluation of fluorescence quenching studies, UV-VIS absorption spectra of quercetin, IR, 
and Q3’S were recorded; these data show negligible absorbance of flavonoids at 6 μM 
concentration (295 nm: A = 0.03-0.05; 344 nm: A = 0.03-0.06) suggesting their insignificant 
inner-filter effect. Fluorescence quenching of albumins by the tested flavonoids were 
evaluated using the graphical application of Stern-Volmer (SV) equation (Eq. 1). SV plots of 
flavonoid-albumin complexes are demonstrated in Fig. 6. SV plots of quercetin show good 
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linearity (R
2
 = 0.990-0.999) regarding each tested albumin, suggestion the static quenching of 
albumins by quercetin and 1:1 stoichiometry of the complex formation. Linearity of IR-BSA, 
IR-HSA, and IR-PSA plots was excellent (R
2
 = 0.996-0.999), and IR-RSA complex gave an 
acceptable fitting as well (R
2
 = 0.989). While Q3’S-HSA complex had a relatively good 
linearity (R
2
 = 0.990), SV plots of other Q3’S-albumin complexes lost their linearity in the 
presence of higher (4-6 μM) Q3’S concentrations (Fig. 6). This shape of the SV function may 
suggest that both static and dynamic components are involved as the quenching mechanism. 
On the other hand, relatively low flavonoid concentrations were applied and their absorbance 
is negligible at the wavelengths used. Another explanation of the poor linearity is the presence 
of more than one binding sites of some flavonoids in the proteins.     
 
3.4. Quantitation of binding constants of flavonoid-albumin complexes   
To determine the stabilities of flavonoid-albumin complexes as well as to test the hypothesis 
that some flavonoids occupy more binding sites on albumins, binding constants of flavonoid-
albumin complexes were determined. During the quantitation of binding constants both the 
data regarding the fluorescence enhancement of flavonoids by albumins (Fig. 2) and data 
from quenching experiments (Fig. 5) were utilized. 
Table 1 represents the binding constants and number of binding sites calculated from the 
quenching experiments employing the SV equation, double logarithm SV equation, and the 
Hyperquad2006 software (see details in the Materials and Methods section). SV equation 
suggested approximately 5.1-5.9 logKSV values, while the double logarithm SV equation 
referred to significantly higher binding constants of some complexes. Based on double 
logarithm SV equation, logKSV and logK values were in a good agreement regarding 
quercetin-BSA, quercetin-HSA, IR-BSA, IR-HSA, IR-PSA, and Q3’S-HSA complexes 
(“group I”); however, other complexes including quercetin-PSA, quercetin-RSA, IR-RSA, 
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Q3’S-BSA, Q3’S-PSA, and Q3’S-RSA (“group II”) showed much higher stabilities (logK = 
6.1-7.8). We also noticed that the latter group showed relatively higher n values (1.16-1.36) 
compared to group I (0.98-1.04). On the other hand, Hyperquad calculations of quenching 
data recommend similar magnitude of binding constants in each case (logK = 5.2-6.1) than 
logKSV data. Using the Hyperquad2006 software, binding constants were also calculated 
assuming 1:2 stoichiometry (two binding sites of ligands in one albumin molecule). In many 
cases, Hyperquad failed to interpret the 1:2 model (the only exception was IR-BSA complex 
among the members of group I), while 1:2 stoichiometry was compatible with every group II 
complexes. 
As Table 2 represents, Hyperquad calculations of 1:1 and 1:2 models were performed using 
the data of the fluorescence enhancement of flavonoids by albumins as well. Using the 1:1 
stoichiometry model, 5.2-6.2 logK values were determined regarding most of the flavonoid-
albumin complexes, with the exceptions of quercetin-RSA, Q3’S-BSA, Q3’S-HSA, Q3’S-
PSA, and Q3’S-RSA (logK = 6.4-7.3). On the other hand, the assumption of 1:2 stoichiometry 
resulted in much lower stabilities of the primary binding sites of these complexes (logK1 = 
5.2-5.8). Furthermore, with the exception of IR-RSA complex, 1:2 stoichiometry was 
compatible with each group II complex. Among group I complexes, only quercetin-BSA and 
Q3’S-HSA showed the possibility of 1:2 stoichiometry. 
Considering the above listed observations, it is plausible to assume that group I members form 
1:1 while group II members support formation of 1:2 complexes. HSA forms 1:1 and RSA 
forms typically 1:2 complexes with flavonoids tested. BSA and PSA can form 1:1 or 1:2 
complexes depending on the ligand molecule. Binding constants of quercetin-, IR-, and Q3’S-
albumin complexes (primary binding sites) are between 10
5
 and 10
6
 dm
3
/mol (or in some 
cases slightly exceeding this range), which correlates well with previous studies regarding 
flavonoid-albumin interactions [42,43]. Stabilities of flavonoid-albumin complexes based on 
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the albumin species can show negligible, moderate, or high differences. Typically 0.1-0.5 
differences of logK values were observed. Flavonoids commonly formed the most stable 
complexes with RSA. 
 
4. Conclusions 
In this study, the fluorescence enhancement of quercetin and its metabolites by different 
albumins (BSA, HSA, PSA, and RSA) was investigated using fluorescence spectroscopy. Our 
major observations and conclusions are the followings. (1) Among the tested compounds, 
fluorescence enhancement of quercetin, IR, and Q3’S was observed in the presence of 
albumins. (2) Depending on the albumin species, the extent of the fluorescence enhancement 
of flavonoids varied considerably. The strongest fluorescence enhancement of quercetin was 
observed in the presence of RSA then followed by PSA, HSA, and BSA (in this order). On 
the other hand, the presence of HSA resulted in the highest enhancement regarding IR, while 
RSA, PSA, and BSA were less effective enhancers of IR (these three IR-albumin complexes 
expressed similar fluorescence). Fluorescence enhancement of Q3’S-albumin complexes 
showed the following order: Q3’S-BSA > Q3’S-PSA > Q3’S-HSA > Q3’S-RSA. BSA was 
highly the most potent enhancer of Q3’S but it showed the lowest effects regarding quercetin 
and IR. HSA caused the strongest enhancement of IR while it was less effective enhancer of 
quercetin and Q3’S (despite the fluorescence of quercetin-HSA, IR-HSA, and Q3’S-HSA 
complexes were similar). PSA was a relatively strong enhancer of quercetin and Q3’S but it 
was poorly effective regarding IR. RSA was the most potent enhancer of quercetin, however, 
it was a weaker enhancer of IR and it was the least potent enhancer of Q3’S. (3) Fluorescence 
enhancement of quercetin, IR, and Q3’S by albumins were examined at non-physiological pH 
levels as well. At pH 5.0 and 10.0, the fluorescence of flavonoid-albumin complexes was 
almost completely abolished, while slight decrease (pH 7.0) reduced and slight increase (pH 
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7.8) generally enhanced the fluorescence of albumin complexes (only quercetin-PSA and 
quercetin-RSA showed weaker fluorescence at pH 7.8 than at pH 7.4). (4) Based on the 
fluorescence enhancement of flavonoids by albumins and quenching experiments, some of the 
formed complexes showed 1:1 stoichiometry (quercetin-BSA, quercetin-HSA, IR-BSA, IR-
HSA, IR-PSA, and Q3’S-HSA), however, in other cases 1:2 stoichiometry was assumed 
(quercetin-PSA, quercetin-RSA, IR-RSA, Q3’S-BSA, Q3’S-PSA, and Q3’S-RSA) suggesting 
that some flavonoids may occupy a secondary binding site on albumins. (5) Despite these 
flavonoids express negligible fluorescence, the strong fluorescence enhancement of quercetin, 
IR, and Q3’S by albumins allows the fluorescence spectroscopic detection of these 
biologically important flavonoids, which may be a suitable tool for their fluorescence 
quantification. Furthermore, fluorescence detection of the described flavonoid-albumin 
complexes make possible to examine some of their molecular interactions by fluorescence 
spectroscopy.   
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Figures: 
 
 
Fig. 1: Chemical structures of quercetin, isorhamnetin, and quercetin-3’-sulfate. 
 
 
 
 
Fig. 2: Fluorescence emission intensities of 2 μM quercetin (Q; left), 2 μM isorhamnetin (IR; 
middle), and 2 μM quercetin-3’-sulfate (Q3’S; right) in PBS (pH 7.4) in the presence of 
increasing concentrations (0-5 μM) of BSA, HSA, PSA, and RSA (quercetin and IR: λex = 
455 nm, λem = 525 nm; Q3’S: λex = 445 nm, λem = 505 nm). 
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Fig. 3: Fluorescence emission spectra of 2 μM quercetin (Q; left), 2 μM isorhamnetin (IR; 
middle), and 2 μM quercetin-3’-sulfate (Q3’S; right) in the presence of increasing 
concentrations (0, 0.5, 1, 1.5, 2, 3, 4, and 5 μM) of RSA, HSA, and BSA, respectively 
(quercetin and IR: λex = 455 nm; Q3’S: λex = 445 nm; PBS, pH 7.4).   
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Fig. 4: Influence of the pH on the fluorescence of flavonoids-albumin complexes. Relative 
fluorescence emission of quercetin (Q; top), isorhamnetin (IR; middle), and quercetin-3’-
sulfate (Q3’S; bottom) in the presence of increasing albumin concentrations (0-5 μM) in PBS 
at pH 7.0, 7.4, and 7.8 (quercetin and IR: λex = 455 nm, λem = 525 nm; Q3’S: λex = 445 nm, 
λem = 505 nm). Because the fluorescence emission signal of a flavonoid-albumin complex 
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determined at pH 7.0 and 7.8 was compared to the signal of the same complex recorded at pH 
7.4, the relative intensities of complexes at pH 7.4 are always 1.0 which is the basis of the 
comparison. 
 
 
 
Fig. 5: Fluorescence quenching of albumins by quercetin-3’-sulfate (Q3’S). Emission spectra 
of BSA (left above), HSA (right above), PSA (left below), and RSA (right below) in the 
presence of increasing Q3’S concentrations (0, 0.5, 1, 2, 3, 4, 5, and 6 μM) in PBS (pH 7.4; 
λex = 295 nm). 
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Fig. 6: Stern-Volmer plots of the fluorescence quenching of albumins (2 μM) by quercetin 
(Q), isorhamnetin (IR), and quercetin-3’-sulfate (Q3’S) in PBS (pH 7.4) (λex = 295 nm, λem = 
344 nm). 
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Tables: 
 
     
Complex 
 
Stern-Volmer 
1:1 
Double logarithm 
Stern-Volmer 
Hyperquad 
1:1  
Hyperquad 
1:2 
logKSV (R
2
) logK (R
2
) n logK (±SD) logK1 (±SD) logK2 (±SD) 
Q – BSA 5.14 (0.997) 5.00 (0.999) 0.98 5.25 (± 0.00)  -  - 
Q – HSA 5.27 (0.999) 5.44 (0.999) 1.03 5.37 (± 0.00)  -  - 
Q – PSA 5.28 (0.993) 6.13 (0.999) 1.16 5.36 (± 0.00) 5.32 (± 0.01) 4.66 (± 0.05) 
Q – RSA 5.51 (0.990) 6.50 (0.999) 1.18 5.65 (± 0.00) 5.64 (± 0.01) 4.26 (± 0.22) 
IR – BSA 5.19 (0.996) 5.39 (0.996) 1.02 5.29 (± 0.00) 5.26 (± 0.01) 4.34 (± 0.12) 
IR – HSA 5.27 (0.997) 5.20 (0.999) 0.98 5.43 (± 0.01)  -  - 
IR – PSA 5.40 (0.999) 5.63 (0.999) 1.04 5.52 (± 0.00)  -  - 
IR – RSA 5.45 (0.989) 6.40 (0.999) 1.18 5.58 (± 0.00) 5.46 (± 0.01) 4.58 (± 0.13) 
Q3'S – BSA 5.60 (0.964) 7.19 (0.999) 1.28 5.80 (± 0.00) 5.76 (± 0.01) 4.93 (± 0.07) 
Q3'S – HSA 5.35 (0.990) 5.28 (0.996) 0.99 5.49 (± 0.01)  -  - 
Q3'S – PSA 5.78 (0.965) 7.81 (0.999) 1.36 6.06 (± 0.00) 6.05 (± 0.00) 4.49 (± 0.10) 
Q3'S – RSA 5.86 (0.979) 7.69 (0.999) 1.34 6.05 (± 0.01) 6.04 (± 0.01) 3.80 (± 0.10) 
 
Table 1: Stern-Volmer quenching constants (KSV), binding constants (K), and number of 
binding sites (n) of flavonoid-albumin complexes calculated from the data of fluorescence 
quenching experiments (see details in the Materials and Methods section). 
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Hyperquad 
1:1 
Hyperquad 
1:2 
logK (±SD) logK1 (±SD) logK2 (±SD) 
Q - BSA 5.33 (± 0.01) 5.32 (± 0.02) 5.26 (± 0.02) 
Q - HSA 6.16 (± 0.05)  -  - 
Q - PSA 5.72 (± 0.01) 5.75 (± 0.03) 4.83 (± 0.02) 
Q - RSA 6.38 (± 0.03) 5.23 (± 0.04) 5.16 (± 0.02) 
IR - BSA 5.26 (± 0.01)  -  - 
IR - HSA 6.05 (± 0.03)  -  - 
IR - PSA 5.70 (± 0.01)  -  - 
IR - RSA 5.94 (± 0.02)  -  - 
Q3'S - BSA 6.63 (± 0.04) 5.41 (± 0.06) 5.22 (± 0.02) 
Q3'S - HSA 6.65 (± 0.04) 5.27 (± 0.02) 5.14 (± 0.12) 
Q3'S - PSA 6.66 (± 0.04) 5.27 (± 0.02) 5.14 (± 0.14) 
Q3'S - RSA 7.31 (± 0.11) 5.46 (± 0.02) 3.67 (± 0.11) 
 
Table 2: Binding constants (K) of flavonoids-albumin complexes calculated from the data of 
the fluorescence enhancement of flavonoids by albumins (see details in the Materials and 
Methods section). 
